Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain zaps help stroke survivors walk better?

NCT ID NCT07531797

Symptom relief Sponsor: Ain Shams University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a non-invasive magnetic stimulation technique applied to the back of the brain (cerebellum) could improve walking and balance in 40 adults with cerebral small vessel disease. Participants received either real or fake stimulation over several sessions. The goal was to see if the real treatment led to better scores on walking tests like the Timed Up and Go test. The study is complete, and results may show whether this approach offers a safe way to ease mobility problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

May 2023

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients included aged 30 years or older. • Presenting with impaired gait DUE TO CSVD, Type I Arteriosclerosis-related CSVD (Hypertension, Diabetes). Or Type IV; Inflammatory/immunologically mediated CSVD: Systematic Vasculitis Exclusion Criteria: Moderate to severe cognitive impairment (excluded by mini mental state test) * Uncontrolled Diabetes mellites (HBA1C \> 7%) * Recent head trauma. * Mental disorders. * Other co-existing neurological disease as Multiple sclerosis, ALS,.. * Other causes of peripheral neuropathy (metabolic disorders, radiation induced, toxic, … etc) * Patients with acute stroke. * Any contraindications for rTMS as skull defects, epilepsy, brain implants, pacemaker or pregnancy. * Vasculitis secondary to CNS infections tuberculosis, syphilis, HIV, leptospirosis.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Balance are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cerebral Small Vessel Diseases Mobility Limitation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Balance Cerebral small vessel disease Gait disorders Repetitive transcranial magnetic stimulation (RTMS)

Contacts and locations

Locations

  • Ain Shams university

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.